HP and gastric cancer: We therefore integrated data from Hp eradication therapy studies in Chinese Hp-positive patients with ≥3 years of follow-up, quantitatively analyzed the therapy's impact on gastric cancer risk, and explored preventive effect differences across subgroups with varying sample sizes.